GS-US-432-4097 – Gilead

GS-US-432-4097 – Gilead

A phase 2, randomised, placebo-controlled, trial evaluating the efficacy and safety of Filgotinib in
subject with active non-infectious uveitis.


Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment